ScripsAmerica, Inc.

SCRCQ

US8110661092

Drug Retailers

Market Closed - OTC Markets Other stock markets 06:40:00 02/12/2023 am IST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2018	AEM Medical Group LLC cancelled the acquisition of 90% equity interest of PIMD International LLC from ScripsAmerica, Inc. (OTCPK:SCRC.Q).	CI
2018	Jaysukh Sabhaya cancelled its acquisition of Pharmacy Administration, Inc. from ScripsAmerica, Inc. (OTCPK:SCRC.Q).	CI

ScripsAmerica, Inc. Provides Earnings Guidance for the Second Half and Year Ended December 31, 2014 and First Quarter of 2015

March 18, 2015 at 05:30 pm IST

ScripsAmerica, Inc. announced that it is currently projecting first quarter 2015 net income of over $400,000 on revenue of over $9.5 million.

The company's preliminary financial reported indicates that revenue for the year ended December 31, 2014 is expected to exceed $31 million.

The company's preliminary financial reported indicates that the company expects to report positive net income and EPS for the second half of 2014.

Latest news about ScripsAmerica, Inc.

AEM Medical Group LLC cancelled the acquisition of 90% equity interest of PIMD International LLC from ScripsAmerica, Inc. (OTCPK:SCRC.Q).	30/18/30	CI
Jaysukh Sabhaya cancelled its acquisition of Pharmacy Administration, Inc. from ScripsAmerica, Inc. (OTCPK:SCRC.Q).	18/18/18	CI
Motion for Joint Administration Approved for ScripsAmerica, Inc.	15/17/15	CI
Motion for Joint Administration Filed by ScripsAmerica, Inc.	28/17/28	CI
Affiliate Company Joined ScripsAmerica, Inc. Bankruptcy	21/17/21	CI
Motion for Asset Sale Approved for ScripsAmerica, Inc.	30/17/30	CI
AEM Medical Group LLC entered into asset purchase agreement to acquire 90% equity interest of PIMD International LLC from ScripsAmerica, Inc. (OTCPK:SCRC.Q) $0.03.	30/17/30	CI
Motion for Asset Sale Filed by ScripsAmerica, Inc.	10/17/10	CI
Motion For Case Conversion Approved for ScripsAmerica, Inc.	08/17/08	CI
Motion for Case Conversion Filed by ScripsAmerica, Inc.	30/17/30	CI
Motion for Asset Sale Approved for ScripsAmerica, Inc.	25/17/25	CI
Notice for Asset Purchase Agreement Filed by ScripsAmerica, Inc.	24/17/24	CI
Jaysukh Sabhaya entered into an asset purchase agreement to acquire Pharmacy Administration, Inc. from ScripsAmerica, Inc. (OTCPK:SCRC.Q) for $0.15 million.	24/17/24	CI
Liquidation Plan and Disclosure Statement Filed by ScripsAmerica, Inc.	16/17/16	CI
First Motion for Exclusivity Period Extension Filed by ScripsAmerica, Inc.	04/17/04	CI
First Motion for Exclusivity Period Extension Withdrawn by ScripsAmerica, Inc.	30/16/30	CI
First Motion for Exclusivity Period Extension Filed by ScripsAmerica, Inc.	15/16/15	CI
Bidding Procedure Approved for ScripsAmerica, Inc.	03/16/03	CI
Motion for Asset Sale Filed by ScripsAmerica, Inc.	14/16/14	CI
ScripsAmerica, Inc. will Change its Ticker to SCRC.Q from SCRC	09/16/09	CI
ScripsAmerica, Inc. Filed for Bankruptcy	07/16/07	CI
ScripsAmerica, Inc. Announces Board Changes	21/16/21	CI
ScripsAmerica, Inc. Announces Resignation of Anderson Triggs as Director	16/16/16	CI
ScripsAmerica, Inc. Reports Earnings Results for the Fiscal 2014	01/16/01	CI
ScripsAmerica Mulls Acquisitions	18/15/18	CI

Chart ScripsAmerica, Inc.

Duration

Period

More charts

Company Profile

ScripsAmerica, Inc. is engaged in the distribution of prescription and over the counter pharmaceuticals. The Company's subsidiaries include Main Avenue Pharmacy Inc. (Main Avenue), DispenseDoc Inc. (DispenseDoc) and Pharmacy Administration, Inc. (Pharmacy Administration). It also holds interests in P.I.M.D. International LLC (PIMD). Its operations consist of the sale and compounding of non-sterile topical and transdermal pain creams through Main Avenue; wholesale sales to independent pharmacies and other medical providers through PIMD; pharmacy dispensing services for individual doctors through DispenseDoc, and billing and administrative services through Pharmacy Administration. Main Avenue's prescription pain creams incorporate approximately eight active pharmaceutical ingredients for application on the skin and in localized areas. As of December 31, 2014, PIMD held licenses in over 20 states to receive, store and ship Schedule 3 through Schedule 5 formulary pharmaceuticals.

Sector

Drug Retailers

More about the company

Sector Other Drug Retailers

	1st Jan change	Capi.
SCRIPSAMERICA, INC.	-.--%	141
WALGREENS BOOTS ALLIANCE, INC.	-38.91%	1.42TCr
JD HEALTH INTERNATIONAL INC.	-29.16%	1.16TCr
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-27.59%	650.95Cr
YIFENG PHARMACY CHAIN CO., LTD.	+15.73%	631.85Cr
MATSUKIYOCOCOKARA & CO.	-8.13%	614.99Cr
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+71.17%	498.44Cr
CLICKS GROUP LIMITED	-6.00%	396.69Cr
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-14.62%	343.05Cr
WELCIA HOLDINGS CO., LTD.	-9.81%	296.46Cr

Other Drug Retailers